Category Archives: Insights

Elon Musk Enters the Home Stretch of His Tesla Share Sales

First American News, Raleigh, NC: Elon Musk offloaded the second batch of Tesla Inc. shares in a matter of days and is now three-quarters of the way done selling 10% of his stake in the company. Tesla’s chief executive officer got rid of 934,091 shares for more than $884 million, according to regulatory filings dated Thursday. The […]

Zomedica Stock News, (ZOM) Is Sinking This Week. See Zomedica 2022 Forecast

Shares of Zomedica (NYSEMKT: ZOM) were sinking 14.8% lower for the week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The reason behind the decline goes back into the previous week, when Zomedica announced its third-quarter results after the market close on Nov. 12. The veterinary health company reported revenue in the […]

Ocugen News: (OCGN) How Long to Wait for FDA Approval?

Ocugen (OCGN) is a biotechnology firm engaging in the development and commercialization of therapies for eye diseases. Its pipeline of therapies includes OCU400, OCU410, OCU200, OCU100, and OCU300. The company was founded in 2013, and is headquartered in Malvern, Pennsylvania. Shares of Ocugen have gains of 71.5% year-to-date, and 12-month gains of 1,655%. I am […]

Why Shares of Ocugen, Pfizer, and Vaxart Are Losing Ground Today

Shares of the COVID-19 vaccine makers Pfizer (NYSE: PFE), Ocugen (NASDAQ: OCGN), and Vaxart (NASDAQ: VXRT) are all moving in the wrong direction today. Specifically, Pfizer’s stock is down by approximately 4%, Ocugen’s equity is in the red by 5.64%, and Vaxart’s shares are underwater by a hefty 8.7%, as of 12:23 p.m. ET Monday […]